Last week, MEDISAFE 1 TECH CORP (OTC:MFTH) got the up move again. After a few days of price hesitations, on Friday the 
stock soared 12.50% and its traded volume started rising up. Now MFTH is determined to hold the gain, no matter how.
On the day when the climb began, UV Flu released a piece of news, stating that the company was in the process of submitting three patent applications for medical safety devices and the team was looking forward to advancing the products to commercial phase.
Apparently, investors were fascinated by the good news, though it wasn’t the only step the company made towards the success. According to the records, along with the optimistic announcement MFTH has been promoted for three days. The campaign finished yesterday and featured the announcement for the three medical patent devices of Medisafe. The promotions cost $32.500 in total, though only one of the paying parties was revealed: Royal Import Inc. Despite this fact, the alerts were meant to hold the up move of MFTH for longer.
Actually, that’s not the first time when Medisafe uses promotions to climb up. Around mid-May, the stock was promoted again by a great number of promotional websites, trying hard to hit the gain. However, at that time the up move was shortly broken. What will happen now is just a matter of time to be seen.
Medisafe 1 Technologies Corp. is a developer of patented technologies aimed to physically prevent unauthorized administration of prescription medications. Last summer, the company used to trade at $1.5 per share, though since then the stock price has moved down significantly.[BANNER]
In the meantime, the financial condition of MFTH remains desperate. According to its 10-Q, since inception the company has not generated any revenue and has financed its operations from the sale of common stock and other securities and loans from investors and related parties. At the same time, the losses continue and the management does not believe that its cash resources will be sufficient to fund the expenses over the next 12 months.
Obviously, instead of finding a way to get profitable, Medisafe keeps relying on optimistic news and promotions to pump up its stock price.
